TIDMSLN

RNS Number : 8210L

Silence Therapeutics PLC

24 April 2018

Results of AGM

London, 24(th) April 2018

Silence Therapeutics plc, AIM:SLN ("Silence" or "the Company") a leader in the discovery, delivery, and development of novel RNA therapeutics for the treatment of serious diseases with unmet medical need, announces that at its Annual General Meeting held on Monday, 23(rd) April 2018, all resolutions were duly passed.

Enquiries:

 
 Silence Therapeutics plc                  Tel: +44 (0)20 3457 6900 
  Ali Mortazavi, Chief Executive Officer 
  David Ellam, Chief Financial Officer 
 
   Peel Hunt LLP (Nominated Adviser          Tel: +44 (0)20 7418 8900 
   and Broker) 
   James Steel/Oliver Jackson 
 Media Enquiries: 
  Optimum Strategic Communications           Tel: +44 (0) 20 3714 1788 
  Mary Clark/ Eva Haas/Hollie Vile 
  silence@optimumcomms.com 
 IR Enquires - US                          Tel: +1 (212) 213 0006 
  Burns McClellan 
  John Grimaldi

Notes to Editors

About Silence Therapeutics plc

Silence Therapeutics develops a new generation of medicines by harnessing the body's natural mechanism of RNA interference, or RNAi, within its cells. Our proprietary technology can selectively inhibit any gene in the genome, specifically silencing the production of disease-causing proteins. Using our enabling delivery systems, we have achieved an additional level of specificity by delivering our therapeutic RNA molecules exclusively to target cells. Silence's proprietary RNA chemistries and delivery systems are designed to improve the stability of our molecules and enhance effective delivery to target cells, providing a powerful modular technology well suited to tackle life-threatening diseases. For more information, please visit: http://www.silence-therapeutics.com/

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGLLFISSRIVFIT

(END) Dow Jones Newswires

April 24, 2018 02:00 ET (06:00 GMT)

Silence Therapeutics (LSE:SLN)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Silence Therapeutics Charts.
Silence Therapeutics (LSE:SLN)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Silence Therapeutics Charts.